Evidence map›Paper›PMID 32145456›Full record

ArticleRedox biology2020

Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery.

Stamatia Laidou, Gregorio Alanis-Lobato, Jan Pribyl, Tamás Raskó, Boris Tichy, Kamil Mikulasek, Maria Tsagiopoulou, Jan Oppelt, Georgia Kastrinaki, Maria Lefaki and 11 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 5 countries.

Stamatia LaidouInstitute of Applied Biosciences/Centre for Research and Technology Hellas, 57001, Thessaloniki, Greece.
Gregorio Alanis-LobatoFaculty of Biology, Johannes Gutenberg University Mainz, 55122, Mainz, Germany; Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.
Jan PribylCentral European Institute of Technology, Masaryk University, 62500, Brno, Czech Republic.
Tamás RaskóMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany.
Boris TichyCentral European Institute of Technology, Masaryk University, 62500, Brno, Czech Republic.
Kamil MikulasekCentral European Institute of Technology, Masaryk University, 62500, Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, 62500, Brno, Czech Republic.
Maria TsagiopoulouInstitute of Applied Biosciences/Centre for Research and Technology Hellas, 57001, Thessaloniki, Greece.
Jan OppeltCentral European Institute of Technology, Masaryk University, 62500, Brno, Czech Republic.
Georgia KastrinakiAerosol and Particle Technology Laboratory/Chemical Process & Energy Resources Institute/Centre for Research and Technology Hellas, 57001, Thessaloniki, Greece.
Maria LefakiInstitute of Biology, Medicinal Chemistry & Biotechnology/National Hellenic Research Foundation, 11365, Athens, Greece.
Manvendra SinghMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany.
Annika ZinkMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany; Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich Heine University, 40225, Düsseldorf, Germany.
Niki ChondrogianniInstitute of Biology, Medicinal Chemistry & Biotechnology/National Hellenic Research Foundation, 11365, Athens, Greece.
Fotis PsomopoulosInstitute of Applied Biosciences/Centre for Research and Technology Hellas, 57001, Thessaloniki, Greece; Department of Molecular Medicine and Surgery, Karolinska Institutet, 17177, Stockholm, Sweden.
Alessandro PrigioneMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany; Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich Heine University, 40225, Düsseldorf, Germany.
Zoltán IvicsDivision of Medical Biotechnology, Paul-Ehrlich-Institute, 63225, Langen, Germany.
Sarka PospisilovaCentral European Institute of Technology, Masaryk University, 62500, Brno, Czech Republic.
Petr SkladalCentral European Institute of Technology, Masaryk University, 62500, Brno, Czech Republic.
Zsuzsanna IzsvákMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany. Electronic address: zizsvak@mdc-berlin.de.
Miguel A Andrade-NavarroFaculty of Biology, Johannes Gutenberg University Mainz, 55122, Mainz, Germany.
Spyros PetrakisInstitute of Applied Biosciences/Centre for Research and Technology Hellas, 57001, Thessaloniki, Greece. Electronic address: spetrak@certh.gr.
Centre for Research and Technology Hellas · GRMax Delbrück Center · DECentral European Institute of Technology · CZCentral European Institute of Technology – Masaryk University · CZJohannes Gutenberg University Mainz · DENational Hellenic Research Foundation · GRDüsseldorf University Hospital · DEKarolinska Institutet · SEPaul Ehrlich Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar ataxia type-1 (SCA1) is caused by an abnormally expanded polyglutamine (polyQ) tract in ataxin-1. These expansions are responsible for protein misfolding and self-assembly into intranuclear inclusion bodies (IIBs) that are somehow linked to neuronal death. However, owing to lack of a suitable cellular model, the downstream consequences of IIB formation are yet to be resolved. Here, we describe a nuclear protein aggregation model of pathogenic human ataxin-1 and characterize IIB effects. Using an inducible Sleeping Beauty transposon system, we overexpressed the ATXN1(Q82) gene in human mesenchymal stem cells that are resistant to the early cytotoxic effects caused by the expression of the mutant protein. We characterized the structure and the protein composition of insoluble polyQ IIBs which gradually occupy the nuclei and are responsible for the generation of reactive oxygen species. In response to their formation, our transcriptome analysis reveals a cerebellum-specific perturbed protein interaction network, primarily affecting protein synthesis. We propose that insoluble polyQ IIBs cause oxidative and nucleolar stress and affect the assembly of the ribosome by capturing or down-regulating essential components. The inducible cell system can be utilized to decipher the cellular consequences of polyQ protein aggregation. Our strategy provides a broadly applicable methodology for studying polyQ diseases.

Indexed as

Intranuclear Inclusion BodiesNerve Tissue ProteinsAtaxin-1HumansNuclear ProteinsOxidative StressAtaxin-1Nerve Tissue ProteinsNuclear ProteinsAtaxin-1Oxidative stressPolyglutamineProtein networkRibosomeSleeping beauty transposon

Identifiers

PMID32145456
PMCPMC7058924
OpenAlexW3006613792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.